Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Clinical Calcium|October 28, 2015
[Bone disease in primary biliary cirrhosis]Hidetaka Shibata, Kazuhiko NakaoJournal of Cellular Biochemistry|January 19, 2010
Pathology and biology associated with the fragile FHIT gene and gene productJoshua C Saldivar, Hidetaka Shibata, Kay HuebnerCancer Science|June 29, 2011
Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibitionHidetaka Shibata, Satoshi Miuma, Joshua C Saldivar, et al.Advances in Enzyme Regulation|November 2, 2010
Hits, Fhits and Nits: beyond enzymatic functionKay Huebner, Joshua C Saldivar, Jin Sun, et al.Molecular and Clinical Oncology|August 8, 2017
Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenibMio Yamashima, Hisamitsu Miyaaki, Takuya Honda, et al.Internal Medicine (Tokyo, Japan)|June 2, 2011
Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndromeHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.Internal Medicine (Tokyo, Japan)|July 17, 2019
The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver DiseaseMio Yamashima, Hisamitsu Miyaaki, Satoshi Miuma, et al.Internal Medicine (Tokyo, Japan)|May 7, 2016
Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver DiseaseHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.Biomedical Reports|December 2, 2015
Predictive value of the efficacy of tolvaptan in liver cirrhosis patients using free water clearanceHisamitsu Miyaaki, Yutaka Nakamura, Tatsuki Ichikawa, et al.Oncology Letters|August 7, 2012
Clinical characteristics of hepatocellular carcinoma in elderly patientsTakuya Honda, Hisamitsu Miyaaki, Tatsuki Ichikawa, et al.Pageof 6